TrialEuropean heart journal2017

Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).

Peter S Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.